White House
White House Unveils ADAPT Program to Advance Biomarker-Guided Cancer Treatment
As part of ARPA-H, ADAPT will fund research into biomarker strategies that adapt to changing tumor biology and ways to translate them into clinical trials.
White House Report Outlines Goals to Advance Genomic Research, Precision Therapy Development
The report, on goals for biotechnology and biomanufacturing in the US, suggests areas of investment including multiomics, cell therapies, gene editing, and microbial genome sequencing.
President Biden Jumpstarts Cancer Moonshot Initiative With Goal of Halving Death Rate
The renewal of the ambitious effort includes the reestablishment of direct White House leadership, with a cross-agency cabinet to drive progress in early detection and care equity.
NCI Director Sharpless Outlines Ideas to Aggressively Lower Cancer Deaths
At the AACR Annual Meeting, Sharpless said NCI should focus on improving early screening, access to trials, and development of advanced drugs to realize President Biden's goal of eradicating cancer.